Search
Search
About
Log in
Join
Experiences with
Olysio
Posts
Communities
12 public posts
Filter results
HCV New Drug Research : AASLD 2015 - Janssen announced OLYSIO plus Sovaldi shows 100% Genotype 4 cure rate in Phase IIa OSIRIS trial
http://hepatitiscnewdrugs.blogspot.com/2015/11/aasld-2015-janssen-announced-olysio.html
http://hepatitiscnewdrugs.blogspot.com/2015/11/aasld-2015-janssen-announced-olysio.html
kcohen
in
HFI Connect - Hepatitis
9 years ago
FDA Updates Labeling for Olysio
https://blog.avella.com/hepatitis-now/fda-updates-labeling-for-
olysio
?utm_campaign=Hepatitis+Now&utm_source=hs_email&utm_medium=email&utm_content=22730173&_hsenc=p2ANqtz--2RKeTVTmErxm1ttb0TIUkqFVeVrg7OIw9Ql7mo-BR55MZSpmeXkhAN6hd0EfQgWnFmnK2IdXy9USkI76An9B0jcONvZF0Z2Bo5DGgY7aBlr5n8E4&_hsmi=22730173
https://blog.avella.com/hepatitis-now/fda-updates-labeling-for-
olysio
?utm_campaign=Hepatitis+Now&utm_source=hs_email&utm_medium=email&utm_content=22730173&_hsenc=p2ANqtz--2RKeTVTmErxm1ttb0TIUkqFVeVrg7OIw9Ql7mo-BR55MZSpmeXkhAN6hd0EfQgWnFmnK2IdXy9USkI76An9B0jcONvZF0Z2Bo5DGgY7aBlr5n8E4&_hsmi=22730173
kcohen
in
HFI Connect - Hepatitis
9 years ago
Olysio / Sovaldi Yields SVR12 in Child-Pugh A Cirrhosis
http://www.healio.com/hepatology/hepatitis-c/news/online/%7B85c2aa47-dc27-4b35-9510-8462fcdb905c%7D/olysiosovaldi-combination-yields-high-svr12-in-child-pugh-a-cirrhosis?utm_source=maestro&utm_medium=email&utm_campaign=hepatology%20news
http://www.healio.com/hepatology/hepatitis-c/news/online/%7B85c2aa47-dc27-4b35-9510-8462fcdb905c%7D/olysiosovaldi-combination-yields-high-svr12-in-child-pugh-a-cirrhosis?utm_source=maestro&utm_medium=email&utm_campaign=hepatology%20news
kcohen
in
HFI Connect - Hepatitis
9 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
FDA OK’s BMS Daklinza (Daclatasvir) to Treat Hep C Genotype 3
However, the pairing is the same price as the combination of Sovaldi and Janssen’s
Olysio
(simeprevir), which is approved to treat genotype 1.
However, the pairing is the same price as the combination of Sovaldi and Janssen’s
Olysio
(simeprevir), which is approved to treat genotype 1.
kcohen
in
HFI Connect - Hepatitis
9 years ago
Harvoni and Sovaldi/Daclatasvir Safer to Mix With HIV Meds
Such DDIs would be expected with 70 percent of the HIV regimens if combined with
Olysio
/Sovaldi, 61 percent with Viekira Pak, 64 percent with Harvoni, and 47 percent with Sovaldi/daclatasvir.
Such DDIs would be expected with 70 percent of the HIV regimens if combined with
Olysio
/Sovaldi, 61 percent with Viekira Pak, 64 percent with Harvoni, and 47 percent with Sovaldi/daclatasvir.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
World Health Organization Throws Weight Behind Hep C Treatments
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s
Olysio
(simeprevir), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s
Olysio
(simeprevir), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
World Health Organization Throws Weight Behind Hep C Treatments
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s
Olysio
(simeprevir), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s
Olysio
(simeprevir), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Olysio-Sovaldi Combo Cures High Rates of Hep C Genotype 1
Twelve weeks of Janssen’s
Olysio
(simeprevir) and Gilead Sciences’ Sovaldi (sofosbuvir) boasted near-perfect cure results in a recent trial treating people with genotype 1 of hepatitis C virus (HCV) who did not have cirrhosis.
Twelve weeks of Janssen’s
Olysio
(simeprevir) and Gilead Sciences’ Sovaldi (sofosbuvir) boasted near-perfect cure results in a recent trial treating people with genotype 1 of hepatitis C virus (HCV) who did not have cirrhosis.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Options for Treating Hepatitis C in Those With Advanced Cirrhosis
Seventy-seven percent (55 of 71) of those with genotype 1 who took Sovaldi and
Olysio
, most of them for 12 weeks, achieved an SVR4, as did 81 percent (13 of 16) of those with genotype 1 who took Sovaldi,
Olysio
and ribavirin for 12 weeks.
Seventy-seven percent (55 of 71) of those with genotype 1 who took Sovaldi and
Olysio
, most of them for 12 weeks, achieved an SVR4, as did 81 percent (13 of 16) of those with genotype 1 who took Sovaldi,
Olysio
and ribavirin for 12 weeks.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Merck’s Hep C Meds Work Well in Treatment-Experienced People
The Phase II C-SALVAGE trial included 79 people who had failed a previous regimen of interferon, ribavirin and either
Olysio
(simeprevir), Incivek (telaprevir) or Victrelis (boceprevir). Results were presented at the 50th International Liver Congress in Vienna, Austria.
The Phase II C-SALVAGE trial included 79 people who had failed a previous regimen of interferon, ribavirin and either
Olysio
(simeprevir), Incivek (telaprevir) or Victrelis (boceprevir). Results were presented at the 50th International Liver Congress in Vienna, Austria.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
WHO Adds New Hepatitis C Drugs to Essential Medicines List
Specifically, the WHO added sofosbuvir (brand name Sovaldi) to the guide, as well as simeprevir (
Olysio
), daclatasvir, ribavirin and the non-nucleoside polymerase inhibitor dasabuvir.
Specifically, the WHO added sofosbuvir (brand name Sovaldi) to the guide, as well as simeprevir (
Olysio
), daclatasvir, ribavirin and the non-nucleoside polymerase inhibitor dasabuvir.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Freeatlast
No side effects with Sovaldi and
olysio
. Does any know of any long term after effects?
No side effects with Sovaldi and
olysio
. Does any know of any long term after effects?
Freeatlast
in
Hepatitis C Trust
10 years ago
Filter results
Clear filters
Posted in
All communities
HFI Connect - Hepatitis
11 results
Hepatitis C Trust
1 result
Sort by
Most Relevant
Newest